Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization

被引:42
作者
Alexandrova, A
Ivanov, A
Chumakov, P [1 ]
Kopnin, B
Vasiliev, J
机构
[1] Russian Acad Sci, Engelgart Inst Mol Biol, Moscow, Russia
[2] Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia
[3] Russian Canc Res Ctr, Inst Cancerogenesis, Moscow, Russia
关键词
p53; cell shape; motility; fibronectin; focal contacts;
D O I
10.1038/sj.onc.1203944
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Effects of p53 expression on cell morphology and motility were studied using the derivatives of p53-null 10(1) mouse fibroblasts with tetracycline-regulated expression of exogenous human p53, Induction of p53 expression was accompanied by significant decrease in extracellular matrix (fibronectin) and reduction of matrix fibrils, diminution of the number and size of focal contacts, decrease of cell areas, establishment of more elongated cell shape and alterations of actin cytoskeleton (actin bundles became thinner, their number and size decreased). Expression of His175 and Gln22/Ser23 p53 mutants caused no such effects. To study the influence of p53 expression on cell motility we used wound technique and videomicroscopy observation of single living cells. It was found that induction of p53 expression led to increase of lamellar activity of cell edge, However, in spite of enhanced lamellar activity p53-expressing cells migrated to shorter distance and filled the narrow wound in longer time as compared with their p53-null counterparts. Possible mechanisms of the influence of p53 expression on cell morphology and motility are discussed.
引用
收藏
页码:5826 / 5830
页数:5
相关论文
共 32 条
  • [21] MIYASHITA T, 1994, ONCOGENE, V9, P1799
  • [22] MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161
  • [23] Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
    Murphy, M
    Ahn, J
    Walker, KK
    Hoffman, WH
    Evans, RM
    Levine, AJ
    George, DL
    [J]. GENES & DEVELOPMENT, 1999, 13 (19) : 2490 - 2501
  • [24] Prives C, 1999, J PATHOL, V187, P112
  • [25] Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest
    Ryan, KM
    Vousden, KH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) : 3692 - 3698
  • [26] Tumor surveillance via the ARF-p53 pathway
    Sherr, CJ
    [J]. GENES & DEVELOPMENT, 1998, 12 (19) : 2984 - 2991
  • [27] The cellular response to p53: the decision between life and death
    Sionov, RV
    Haupt, Y
    [J]. ONCOGENE, 1999, 18 (45) : 6145 - 6157
  • [28] p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression
    Sun, YB
    Sun, Y
    Wenger, L
    Rutter, JL
    Brinckerhoff, CE
    Cheung, HS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) : 11535 - 11540
  • [29] PTCF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway
    Tan, MJ
    Wang, YX
    Guan, KL
    Sun, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) : 109 - 114
  • [30] Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains
    Venot, C
    Maratrat, M
    Sierra, V
    Conseiller, E
    Debussche, L
    [J]. ONCOGENE, 1999, 18 (14) : 2405 - 2410